How to Make Meaningful Moves Toward Health Equity in Cancer Care Addressing the three R's: resources, research, and racism Feb 27, 2023
Cancer Drugs That Didn't Work; Another HIV Cure; Kiss of Success With Mistletoe News, features, and commentary about cancer-related issues Feb 24, 2023
Combo Falters in Papillary Renal Cancer, but Some Promise in MET-Driven Subset Over 50% of patients with advanced MET-driven tumors responded to savolitinib plus durvalumab Feb 24, 2023
Gene Tx Shows Sustained Bleeding Control in Severe Hemophilia A at 2 Years Model predicts valoctocogene roxaparvovec could maintain mild hemophilia levels for 5 years Feb 23, 2023
ICI/TKI Combo Maintains Survival Benefit in Advanced RCC Updated trial data show nivolumab/cabozantinib doublet "is getting better with age" Feb 20, 2023
Pembrolizumab Active in BCG-Unresponsive Papillary High-Risk Bladder Cancer KEYNOTE-057 trial results suggest DFS benefit for patient population with unmet need Feb 19, 2023
Escalated ADT Falls Short in Men With High-Risk Features After Prostatectomy But add-on abiraterone and apalutamide may offer some benefits in those with higher PSA Feb 18, 2023
Add-On Olaparib Continues to Show Benefit in First-Line Treatment of mCRPC Final PROpel analysis also shows trend toward overall survival improvement with PARP inhibitor Feb 17, 2023
Adding Talazoparib to Enzalutamide Boosts PFS in Metastatic Prostate Cancer Combination achieved a 37% reduction in risk of progression, death versus ARPI alone Feb 17, 2023
Rucaparib Gets a Win in Metastatic Castration-Resistant Prostate Cancer Benefit in selected patients seen over physician's choice of docetaxel or second-generation ARPI Feb 16, 2023
Targeted Agents Go Head-to-Head for Newly Diagnosed Ph+ ALL Trial crowns a winner, but how relevant is it amid the changing therapeutic landscape for ALL? Feb 16, 2023
If It Resembles Cancer but Doesn't Act Like Cancer, Is It Cancer? Physicians must consider patient perspectives on the Gleason 6 debate Feb 16, 2023
Safe to Omit RT After Lumpectomy in Certain Older Breast Cancer Patients Radiotherapy reduced local recurrence, but showed no effect on OS, distant recurrence Feb 15, 2023
The 'Extreme' Story of How Two Game-Changing Cancer Drugs Came to Market New book by former Forbes senior editor pulls back the curtain on drug development Feb 13, 2023
FDA Has Concerns on 'Unprecedented' Plan for Dostarlimab in Rectal Cancer Panel will discuss if single-arm trials and proposed endpoints are adequate to support approval Feb 08, 2023
Biden Pledges to Extend Medicare's Solvency for 'At Least Two Decades' Healthcare featured prominently in president's State of the Union address Feb 08, 2023
AI Tool Forecasts Lung Cancer Risk From a Single CT Scan Experts give high marks to performance of "Sybil" in predicting disease over 6 years Feb 07, 2023
Risk Model-Based Lung Cancer Screening More Cost-Effective Than USPSTF Recs Risk prediction models more sensitive than age-, smoking history-based methods Feb 07, 2023
Patients' Defensive Thinking May Hinder Colorectal Cancer Screening Study explored why people refused at-home stool test Feb 06, 2023
Novel 'Off the Shelf' CAR-T Product Shows Promise in Myeloma Researchers say safety, efficacy of ALLO-715 comparable to autologous anti-BCMA products Feb 02, 2023
Bispecific Antibody Active in Relapsed/Refractory Small Cell Lung Cancer A majority of patients obtained disease control with tarlatamab; responses proved durable Feb 01, 2023
FDA Greenlights First Drug for ESR1-Mutated Breast Cancer Elacestrant almost doubled PFS versus standard endocrine therapy in advanced ER+/HER2- disease Jan 30, 2023
Immunotherapy Survival Gains 'Less Impressive' in Older Lung Cancer Patients Study finds median OS improvement of just 1 month for patients 75 and older Jan 26, 2023
MDM2 Inhibitor Breaks Through in Trial of Liposarcoma, Other Advanced Malignancies Intermittent dosing dramatically reduced myelosuppression that has hindered drug class Jan 26, 2023
New Class of Factor VIII Replacement Therapy Prevents Bleeds in Severe Hemophilia A Weekly dosing with efanesoctocog alfa reduced annualized bleeding rate by 77% Jan 25, 2023
Inflammatory VEXAS Syndrome May Not Be So Uncommon Is new disease being missed by physicians? Jan 24, 2023
Neoadjuvant Chemo Reduces Disease Recurrence in Operable Colon Cancer Consider it now "an option" for locally advanced disease, editorialists say Jan 24, 2023
New Standard of Care for Refractory Metastatic Colorectal Cancer Significant improvement in OS, PFS with addition of bevacizumab to trifluridine/tipiracil Jan 23, 2023
What Caused a Man to Develop Friable Bleeding Nodules on His Arms and Hips? The cause lies in a lengthy history of cancer treatment, confirmed by histopathology analysis Jan 23, 2023
'More Is Not Better' in Two First-Line Trials for Biliary Tract Cancer No survival benefit with three-drug chemo regimen or clear PFS gain with anti-PD-L1/bevacizumab Jan 22, 2023
New First-Line Standard for Metastatic Pancreatic Cancer Liposomal irinotecan regimen boosts outcomes, although expert expressed concern about toxicity Jan 22, 2023
Adding Targeted Drug to Chemo Boosts Survival in Gastric/GEJ Cancer Longest overall survival reported to date with the addition of zolbetuximab to chemotherapy Jan 21, 2023
We're Underutilizing Genetic Testing for Colorectal Cancer Universal germline testing should be part of the standard of cancer care Jan 20, 2023
Perioperative Chemo Matches Multimodal Tx for Locally Advanced Esophageal/GEJ Cancer Nearly identical 3-year survival, questioning the need for radiotherapy before surgery Jan 20, 2023
Circulating Tumor DNA Could Guide Use of Chemo in Colorectal Cancer Identified patients likely to benefit following surgery, large prospective study showed Jan 19, 2023
Short-Course Apalutamide to Reduce Active Surveillance Attrition in Prostate Cancer Editorialists question whether any intervention violates principles of surveillance Jan 17, 2023
Epstein-Barr Virus Tracking After Liver Transplant May Cut Rare Complication Observational study provides suggestive evidence Jan 17, 2023
The Unfulfilled Promise of Cannabis for Cancer-Related Symptoms Medical cannabis is currently too far removed from the standards of medical practice Jan 14, 2023
For People With HIV, Early Anal Cancer Screening Tied to Better Outcomes All people with HIV should be screened, not just men who have sex with men, researchers say Jan 13, 2023
